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Introduction
Gastric cancer is one of the most common forms of can-
cer worldwide, with approximately 870,000 new cases
and 650,000 deaths per year.1,2 Of those, 85% are ade-
nocarcinoma, with 15% due to lymphoma, gastroin-
testinal stromal tumor and leiomyosarcoma. Gastric
cancer spreads by direct extension through the gastric
wall and, therefore, surrounding tissues or organs such
as the pancreas, colon or liver, could be involved. It also
spreads via the lymphatics or by seeding peritoneal sur-
faces. Most frequently, gastric cancer spreads to intra-
abdominal or supraclavicular lymph nodes (Virchow’s
nodes). Metastatic lymph nodes in the periumbilical
area (Sister Mary Joseph’s nodes) are not uncommon.
Gastric cancer can also spread to the ovary and is called
Krukenberg’s tumor. In the hematogenous spread of
gastric cancer, the liver is the most common site.
Compared with its counterpart of Krukenberg’s tumor,
which is most possibly spread via the lymphatics,3,4 the
incidence of gastric cancer with metastasis to the testis is
quite rare. We present a case of gastric cancer with
unusual initial symptoms of testicular metastasis and a
favorable response to chemotherapy with docetaxel and
cisplatin.
Case Report
A 23-year-old male suffered from progressive right
testis swelling and pain for 2 weeks. He denied other
constitutional symptoms such as fever, epigastralgia,
poor appetite, and body weight loss. Family history
revealed that his father had died of thyroid cancer when
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he was a child. He was treated as having epididymitis
and was given antibiotics by a general practitioner, but
this was unsuccessful. The patient then came to our
hospital. Physical examination showed right spermatic
cord tenderness, and the swollen right testis had a hard
texture and was the size of a golf ball.
Biochemistry and hemogram showed mild hypo-
natremia (Na, 134 mmol/L; normal range, 137–147
mmol/L) and mild normocytic normochromic ane-
mia (hemoglobin, 11.2 g/dL; normal range, 14–18 g/
dL). The tumor markers α-fetoprotein (3.87 ng/mL),
carcinoembryonic antigen (1.82ng/mL) and β-human
chorionic gonadotropin (0.1 mIU/mL) were all within
normal limits (normal ranges: α-fetoprotein, < 20 ng/
mL; carcinoembryonic antigen, < 6 ng/mL; β-human
chorionic gonadotropin, < 10 mIU/mL). Sonography
showed a heterogeneous nodule, with a size of 2.4 ×
3.2 cm, in the right testis (Figure 1). Malignancy was
suspected.
The patient was admitted to our hospital and right
radical orchiectomy was carried out. Pathology showed
a metastatic adenocarcinoma (Figure 2). Hyperch-
romatic and pleomorphic neoplastic cells of signet ring
cell type were noted. The tumor cells were immunore-
active for cytokeratin AE1/AE3, but were nonreac-
tive for CD117 and placental alkaline phosphatase
(Figures 2C–E). Abdominal computed tomography
revealed a thickened gastric wall and a moderate
amount of ascites with diffuse increased soft tissue den-
sity of the subhepatic peritoneal wall, mesentery, pelvic
side wall and rectovesical pouch, indicating gastric
cancer with tumor seeding (Figure 3A). Esophago-
gastroscopy showed ulcerative lesions with bleeding in
the stomach (Figure 4A). Pathology showed adeno-
carcinoma with the same morphology as that of the
previous specimen from orchiectomy (Figures 4B and
4C). The diagnosis of gastric adenocarcinoma with
right testicular metastasis was confirmed.
The patient received 2 cycles of docetaxel and cis-
platin (docetaxel 36 mg/m2 and cisplatin 30 mg/m2
on day 1 and day 8, plus oral tegafur/uracil 300 mg/
m2/day and leucovorin 90 mg/day in 3 divided doses
on day 1 to day 14 in a 21-day cycle). Abdominal full-
ness and appetite improved, and the patient’s general
condition was also good. Follow-up abdominal com-
puted tomography showed a regressive change of the
thickened gastric wall and peritoneal seeding (Figure
3B). However, relapse with a skin lesion over the pa-
tient’s scalp was found after 6 cycles of chemotherapy.
A biopsy was carried out, which showed metastatic
adenocarcinoma. The response duration was 3 months.
Chemotherapy was changed to cisplatin 30 mg/m2,
5-fluorouracil 2,200 mg/m2, and leucovorin 120 mg/
m2 intravenous infusion every week for 8 weeks with
stable disease.
Discussion
Testicular mass lesions can result from neoplasms, infec-
tious diseases or structural disorders. Among neoplastic
diseases, the most common is primary germ cell tumor,
constituting 95% of all testicular neoplasms, while
metastatic testicular tumors make up approximately
2%.5 Infectious diseases, such as epididymo-orchitis, are
not uncommon clinically. Structural disorders include
hydrocele, inguinal hernia, torsion and cysts. Fever,
pain, urinary symptoms or constituent symptoms
often accompany infectious origin, while neoplastic
disorders are usually painless. The diagnostic steps
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Figure 1. (A) Sagittal view of ultrasound shows a hypoechoic mass (arrow), measuring 2.2 × 3.6 cm, in the right testis. A moderate
amount of hydrocele can be observed around the testis. (B) Normal left-side testis.
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include determination of clinical history, tumor marker
measurement, and most importantly, ultrasound exami-
nation. Clinical history is important, as conditions such
as tumors or hydrocele often develop gradually and are
chronic, but infection or torsion often appears suddenly.
In our case, swelling and pain of the right testis was
noted initially and, therefore, infectious disease could
not be excluded and a trial of antibiotics was the logical
choice. However, follow-up was necessary for fear of
etiologies other than infectious disease. An interval of
1 week for follow-up is recommended according to
expert opinion.6
Metastasis to the testis is reported to be as low as
0.02–0.25% of all autopsies.5 Other than leukemia
and lymphoma, the most common origins of second-





Figure 2. (A) Testis and tumor cells (arrow). (B) Epididymis and
tumor cells (arrow). Hyperchromatic and pleomorphic neoplastic
cells of signet ring cell type can also be noted. (C) Tumor cells are
immunoreactive for cytokeratin AE1/AE3. Tumor cells are nonreac-
tive for: (D) CD117 and (E) placental alkaline phosphatase.
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melanoma (11%) and kidney (9%).7 Gastric cancer with
testicular metastasis is reported to be rare.8,9 Several
routes of spread of gastric cancer are postulated, includ-
ing lymphatic, hematogenous, and retrograde extension
through the vas deferens. In our patient, we performed
designated stains for cytokeratin AE1/AE3, placental
alkaline phosphatase and CD117. Cytokeratin AE1/
AE3 is well suited to distinguish epithelial carcinoma
from non-epithelial malignancies, while placental
alkaline phosphatase and CD117 are sensitive markers
of germ cells, and their negativity is useful for excluding
seminomas/dysgerminomas.10,11
Gastric cancer with metastasis to the testis can be
presumed to be Krukenberg’s tumor in males. In our
case, peritoneal carcinomatosis, ascites and regional
lymphadenopathy were found. There was no previous
history of surgery. Although a “true” Krukenberg’s
tumor spreading through the lymphatics was highly 
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Figure 4. (A) Huge gastric ulcer with bleeding. (B) Pathology of gas-
tric ulcer shows residual gastric gland cells and tumor cells. (C)
Immunoreactivity for cytokeratin.
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suspected based on previous studies,3,4 the possible
route of spread in this case could not be confirmed.
Transperitoneal seeding is probable since peritoneal
carcinomatosis was present.
Chemotherapy regimens for advanced gastric cancer
include 5-fluorouracil, cisplatin, etoposide and mito-
mycin, but the response is poor if singly used.12,13
Several new agents used in combination with the above,
including paclitaxel, docetaxel, irinotecan and epiru-
bicin, have shown better activity against gastric can-
cer.14–18 The clinical course and treatment results of
our patient are similar to those of a recent report in
which gastric cancer did not have testicular metastasis
and was treated with docetaxel plus cisplatin and fluo-
rouracil.18 Although there are many agents for combi-
nation therapy of gastric cancer, there is no standard
first-line chemotherapy with a superior effect compared
with other therapies. The time to tumor progression,
toxicity and side effects must be taken into considera-
tion and they are largely dependent on the patient’s age,
performance status and comorbidity. Many clinical tri-
als are underway with results pending. In our case, 2
cycles of docetaxel and cisplatin were used and follow-
up abdominal computed tomography showed effective
results with this regimen. Gastric adenocarcinoma
may present as a testicular mass and has a response 
to docetaxel-and-cisplatin-based chemotherapy that is
similar to that of other gastric adenocarcinomas.
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